Currently Viewing:
Newsroom
Currently Reading
Precursor to Blood Cancer Puts Patients at Risk Indefinitely, Study Finds
January 20, 2018 – Laura Joszt
Study Finds Prior Authorization Mandates for PCSK9 Drugs Raise Questions of Access
January 19, 2018 – Mary Caffrey
Long-Term Oral Contraceptive Use Associated With Reduced Risk of Ovarian, Endometrial Cancer
January 19, 2018 – Jaime Rosenberg
This Week in Managed Care: January 19, 2018
January 19, 2018
Wearable Biosensors Have No Significant Impact on Clinical Outcomes
January 19, 2018 – Kaitlynn Ely
Proposed Drug to Treat Oculopharyngeal Muscular Dystrophy Gains Orphan Drug Designation
January 19, 2018 – Kelly Davio
What We're Reading: House Passes CHIP Funding; Cancer Blood Test; Drug Policy Office Budget
January 19, 2018 – AJMC Staff
AJMC® in the Press, January 19, 2018
January 19, 2018 – AJMC Staff
Risk-Targeted Lung Cancer Screening Shows Modest Benefits
January 19, 2018 – Samantha DiGrande

ASTRO's New Guidelines on Post-operative Radiation Therapy for Endometrial Cancer

The American Society for Radiation Oncology (ASTRO) has issued a new guideline, The Role of Postoperative Radiation Therapy for Endometrial Cancer: An ASTRO Evidence-Based Guideline, that details the use of adjuvant radiation therapy in the treatment of endometrial cancer. The guideline's executive summary is published in the May-June 2014 issue of Practical Radiation Oncology (PRO), the official clinical practice journal of ASTRO. The full-length guideline is available as an open-access article online.
The American Society for Radiation Oncology (ASTRO) has  issued a new guideline, “The Role of Postoperative Radiation Therapy for Endometrial Cancer: An  ASTRO Evidence-Based Guideline,” that details the use of adjuvant radiation therapy in the  treatment of endometrial cancer. The guideline’s executive summary is published in the May-June  2014 issue of Practical Radiation Oncology (PRO), the official clinical practice journal of ASTRO.

The  
full-length guideline is available as an open-access article online at www.practicalradonc.org.  ASTRO’s Guidelines Panel of 17 leading gynecologic specialists compiled and reviewed  extensive data from 330 studies from MEDLINE, EMBASE and the Specialized Register of the  Cochrane Gynaecological Cancer Review Group published from 1980 to 2011. The data population  selected for the guideline was defined as women of all races, age 18 or older, with stage I-IV  endometrial cancer of any histologic type or grade. The studies included patients who underwent a  hysterectomy followed by no adjuvant therapy, or pelvic and/or vaginal brachytherapy with or  without systemic chemotherapy. The panel identified five key questions about the role of adjuvant radiation therapy and developed a series of recommendations to address each question. 


Read the press release here: http://bit.ly/QEFuo9

Source: ASTRO


 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!